Plerixafor ‘on demand’: results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.
Farina L
Bone Marrow Transplant. 2013 Dec 9;49(3):453-5. doi: 10.1038/bmt.2013.193
Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor: an algorithm for the pre-emptive use of plerixafor.
Farina L
Leuk Lymphoma. 2013 Jun 14;55(2):331-6. doi: 10.3109/10428194.2013.802783
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
Locatelli SL
Leukemia. 2013 Jan 30;27(8):1677-87. doi: 10.1038/leu.2013.28
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
Guidetti A
Br J Haematol. 2012 May 10;158(1):108-19. doi: 10.1111/j.1365-2141.2012.09139.x
Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates.
Carlo-Stella C
Stem Cells. 2006 Sep 28;25(1):252-61.
Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor.
Carlo-Stella C
Exp Hematol. 28(2):216-24.
Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing.
Cilloni D
Bone Marrow Transplant. 23(5):497-503.
Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.
Ansaloni L
Br J Cancer. 2014 Dec 2;112(2):306-12. doi: 10.1038/bjc.2014.602
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models.
Morosi L
J Exp Clin Cancer Res. 2021 Sep 10;40(1):286. doi: 10.1186/s13046-021-02070-x
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.
Della Porta MG
Blood. 2014 Feb 20;123(15):2333-42. doi: 10.1182/blood-2013-12-542720